Sicherheitswarnungen & Rückrufmeldungen
Was bedeutet das?
This recall for Glyburide and Metformin 2.5 mg/500 mg tablets was issued at a warehouse/pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. However, you may wish to check your prescription - if any of your tablets look bigger than usual or if they look different than what you normally receive, take your prescription to your pharmacist to examine.
If you take Glyburide and Metformin 2.5 mg/500 mg tablets and have any concerns, you should consult with your physician.
Ongoing Recall Of Single Lot of Glyburide and Metformin 2.5 mg/500 mg Tablets
Dr. Reddy's Laboratories is recalling a single lot of the combination medicine Glyburide and Metformin 2.5 mg/500 mg tablets. Lot number 18007859 is being recalled because this lot may have both Glyburide and Metformin 2.5 mg/500 mg tablets and Glyburide and Metformin 5 mg/500 mg tablets in the same bottle.
This combination tablet contains Glyburide and Metformin is commonly used in the treatment of diabetes. It is also sold under the brand name Glucovance. This recall alert only applied to a single lot of the generic Glyburide and Metformin 2.5 mg/500 mg tablets from Dr. Reddy's. No other Glyburide and Metformin or Glucovance products were involved in this recall.
To view the FDA notice about this recall, please visit: weitere Informationen hier